Literature DB >> 10878873

Routine hepatitis B immunisation in India: cost-effectiveness assessment.

M A Miller1, M Kane.   

Abstract

Based on World Bank guidelines, hepatitis B immunization would be an excellent public health investment, saving each life year for well below the per-capita gross domestic product. This would be one of the most cost-effective investments India could make in the field of health.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10878873     DOI： 10.1007/bf02758178

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


  9 in total

1.  Prevalence of HBsAg & anti-HBs in children & strategy suggested for immunisation in India.

Authors:  B N Tandon; M Irshad; M Raju; G P Mathur; M N Rao
Journal:  Indian J Med Res       Date:  1991-11       Impact factor: 2.375

2.  The prevalence of markers for hepatitis B and human immunodeficiency viruses, malarial parasites and microfilaria in blood donors in a large hospital in south India.

Authors:  A Singhvi; R B Pulimood; T J John; P G Babu; B U Samuel; T Padankatti; R H Carman
Journal:  J Trop Med Hyg       Date:  1990-06

3.  Markers for transfusion-transmissible infections in north Indian voluntary and replacement blood donors: prevalence and trends 1989-1996.

Authors:  A Nanu; S P Sharma; K Chatterjee; P Jyoti
Journal:  Vox Sang       Date:  1997       Impact factor: 2.144

Review 4.  Hepatitis B virus. The major etiology of hepatocellular carcinoma.

Authors:  R P Beasley
Journal:  Cancer       Date:  1988-05-15       Impact factor: 6.860

5.  Prevalence of Australia antigen and antibody and its subtypes in India.

Authors:  R N Dutta; A K Dutta
Journal:  J Indian Med Assoc       Date:  1977-10-16

6.  Dynamics and impact of perinatal transmission of hepatitis B virus in North India.

Authors:  N C Nayak; S K Panda; A J Zuckerman; M K Bhan; D K Guha
Journal:  J Med Virol       Date:  1987-02       Impact factor: 2.327

7.  Prevalence of hepatitis B virus infection in healthy persons in North India.

Authors:  M Irshad; Y K Joshi; S K Acharya; B N Tandon
Journal:  Natl Med J India       Date:  1994 Sep-Oct       Impact factor: 0.537

8.  Hepatitis B virus infection in northern India. Prevalence, subtypes, and seasonal variation.

Authors:  S R Pal; N L Chitkara; S Choudhury; D V Dutta; S D Deodhar; P N Chhuttani
Journal:  Bull World Health Organ       Date:  1974       Impact factor: 9.408

9.  Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States.

Authors:  W Szmuness; C E Stevens; E J Harley; E A Zang; W R Oleszko; D C William; R Sadovsky; J M Morrison; A Kellner
Journal:  N Engl J Med       Date:  1980-10-09       Impact factor: 91.245
  9 in total
  5 in total

1.  Global alliance on vaccines and immunizations. Save the Children UK had concerns about alliance that went further than report did.

Authors:  Gill Walt; Ruairi Brugha; Mary Starling; R K Ojha; Jacob Abraham; Meenakshi Khosla; Jacob M Puliyel
Journal:  BMJ       Date:  2002-04-20

2.  Routine hepatitis B immunization in India: cost effectiveness needs reassessment.

Authors:  Jacob M Puliyel; Riju Mittal; Vineet Tyagi; Sangeeta Gupta
Journal:  Indian J Pediatr       Date:  2003-02       Impact factor: 1.967

3.  Using gross national product to calculate acceptable immunisation costs: deploying cost-effectiveness calculations in reverse.

Authors:  Vineet Tyagi; Saroj K Singh; Ashu Sawhney; Vikas Taneja; Jacob M Puliyel
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

Review 4.  Should universal hepatitis B immunisation be introduced in the UK?

Authors:  P English
Journal:  Arch Dis Child       Date:  2006-04       Impact factor: 3.791

5.  Uptake of newer vaccines in Chandigarh.

Authors:  Sonia Puri; Vikas Bhatia; Amarjit Singh; H M Swami; Amrit Kaur
Journal:  Indian J Pediatr       Date:  2007-01       Impact factor: 5.319
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.